Evidence map›Paper›PMID 31938211›Full record

ArticleInternational journal of clinical and experimental pathology2018

miR-944 inhibits cell migration and invasion by targeting MACC1 in nasopharyngeal carcinoma.

Juanjuan Ji, Yi Peng, Tao Niu, Yunhong Lin, Yan Lin, Xudong Li, Xiaoguang Wu, Zhiyong Huang, Ling Zhong, Shinan Zhang

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Juanjuan JiThe Second People's Hospital of Yunnan Province Kunming, China.
Yi PengThe Affiliated Stomatology Hospital of Kunming Medical University Kunming 650500, Yunnan Province, China.
Tao NiuThe Affiliated Stomatology Hospital of Kunming Medical University Kunming 650500, Yunnan Province, China.
Yunhong LinThe Affiliated Stomatology Hospital of Kunming Medical University Kunming 650500, Yunnan Province, China.
Yan LinThe First Affiliated Hospital of Kunming Medical University Kunming, China.
Xudong LiThe Affiliated Stomatology Hospital of Kunming Medical University Kunming 650500, Yunnan Province, China.
Xiaoguang WuThe First Affiliated Hospital of Kunming Medical University Kunming, China.
Zhiyong HuangThe Affiliated Stomatology Hospital of Kunming Medical University Kunming 650500, Yunnan Province, China.
Ling ZhongThe First Affiliated Hospital of Kunming Medical University Kunming, China.
Shinan ZhangThe Affiliated Stomatology Hospital of Kunming Medical University Kunming 650500, Yunnan Province, China.
Kunming Medical University · CNSecond People's Hospital of Yunnan Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasopharyngeal carcinoma (NPC) is a common disease in Southern China with high prevalence. miR-944 has been reported to play a vital role in progression of a variety of cancers. The present study aimed to investigate the potential role of miR-944 in NPC cell migration and invasion through elucidating the interaction with its target genes, MACC1. Expression of miR-944 in NPC tissues and cell lines was examined with quantitative RT-PCR. Overexpressed miR-944 and suppressed miR-944 were established with miR-944 mimics and miR-944 inhibitor, respectively. The effect of miR-944 on cell migration and invasion was determined using Transwell cell migration and Matrigel invasion assay. Luciferase assay was used to determine the target of miR-944. Knocked down of MACC1 was done by MACC1 siRNA. Expression of MET related-markers was examined using Western blot analysis. The expression level of miR-944 was downregulated in NPC tissues and cell lines. Overexpression of miR-944 significantly inhibited the cell migration and invasion in NPC 6-10B cells. In contrast, suppression of miR-944 promoted cell migration and invasion in NPC C-6661 cells. MACC1 is a direct target of miR-944. MACC1 expression was repressed in miR-944 mimic transfected cells while it was enhanced in miR-944 inhibitor transfected cells. MACC1 knock down inhibited cell migration and invasion. Either miR-944 restoration or MACC1 knockdown caused enhanced E-cadherin, reduced N-cadherin, and vimentin expression. In conclusion, miR-944 could inhibit MET and metastasis of NPC by targeting MACC1. This study suggests that miR-944 has anti-tumor and anti- metastatic properties and could thus be a novel therapeutic agent for NPC treatment.

Indexed as

cell migrationinvasionMACC1miR-944Nasopharyngeal carcinoma

Identifiers

PMID31938211
PMCPMC6958143
OpenAlexW3027646109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.